Literature DB >> 2879986

Necropsy findings in HTLV-I associated myelopathy.

S Akizuki, O Nakazato, Y Higuchi, K Tanabe, M Setoguchi, S Yoshida, Y Miyazaki, S Yamamoto, S Sudou, K Sannomiya.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2879986     DOI： 10.1016/s0140-6736(87)91984-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy.

Authors:  K Sasaki; I Morooka; H Inomata; N Kashio; T Akamine; M Osame
Journal:  Br J Ophthalmol       Date:  1989-10       Impact factor: 4.638

2.  Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type I (HTLV-I) isolated from patients with HTLV-I-associated myelopathy or encephalopathy.

Authors:  J Iwata; T Oka; M Furihata; H Sonobe; K Matsubayashi; Y Uemura; I Miyoshi; Y Ohtsuki
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.

Authors:  M Ishioka; K Goto; S Nakamura; N Watanabe; E Uchio; K Saeki; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

Review 4.  The myeloneuropathies of Jamaica.

Authors:  O St Clair Morgan
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

5.  An autopsy case of human T lymphotropic virus type I-associated myelopathy (HAM) with a duration of 28 years.

Authors:  S Sasaki; T Komori; S Maruyama; M Takeishi; Y Iwasaki
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.

Authors:  Y Kuroda; H Takashima; A Ikeda; C Endo; R Neshige; R Kakigi; H Shibasaki
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

7.  Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.

Authors:  A Ono; M Mochizuki; K Yamaguchi; N Miyata; T Watanabe
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

8.  Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro.

Authors:  T Akagi; Y Hoshida; T Yoshino; N Teramoto; E Kondo; K Hayashi; K Takahashi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.

Authors:  M Kannagi; H Shida; H Igarashi; K Kuruma; H Murai; Y Aono; I Maruyama; M Osame; T Hattori; H Inoko
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection.

Authors:  Y Iwasaki; Y Ohara; I Kobayashi; S Akizuki
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.